National Institute of Allergy and Infectious Diseases; Notice of Meeting, 58167-58168 [2024-15710]
Download as PDF
<![CDATA[
58167
Federal Register / Vol. 89, No. 137 / Wednesday, July 17, 2024 / Notices
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Melissa Furness, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 4162,
Silver Spring, MD 20993, 240–402–
8912; or James Myers, Center for
Biologics Evaluation and Research,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, Rm.
7301, Silver Spring, MD 20993–0002,
240–402–7911.
SUPPLEMENTARY INFORMATION: In the
Federal Register of May 29, 2024, FDA
published a notice with a 60-day
comment period to request comments
on the draft guidance for industry
entitled ‘‘Platform Technology
Designation Program for Drug
Development.’’ The Agency has
received a request for a 30-day
extension of the comment period. The
request conveyed concern that the
current 60-day comment period does
not allow sufficient time to develop a
meaningful or thoughtful response to
the draft guidance.
FDA has considered the request and
is extending the comment period for 30
days, until August 28, 2024. The Agency
believes that a 30-day extension allows
adequate time for interested persons to
submit comments on this draft
guidance.
Dated: July 11, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024–15696 Filed 7–16–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–0477]
Agency Information Collection
Revision 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection reinstatement for public
comment.
SUMMARY:
Comments on the ICR must be
received on or before August 16, 2024.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain . Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
DATES:
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 264–0041, or PRA@HHS.GOV.
When submitting comments or
requesting information, please include
the document identifier 0990–New–30D
and project title for reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Incident Report
Form.
Type of Collection: Reinstatement
with Change.
OMB No.: 0990–0477.
Abstract: The Office of the Assistant
Secretary for Health, Office for Human
Research Protections (OHRP), is
requesting reinstatement of the OMB
No. 0990–0477, Incident Report Form,
with two new information elements on
the Incident Report form: IORG # for
Reviewing IRB; and, Revising research
policies and procedures as a corrective
action plan category, if it applies. The
purpose of the Incident Report form is
to facilitate organizations or institutions
prompt reporting of specific human
subject protection incidents to OHRP, in
a simplified standardized format, as
required by HHS protection of human
subjects regulations at 45 CFR part 46.
ANNUALIZED BURDEN HOUR TABLE
Number of
respondents
ddrumheller on DSK120RN23PROD with NOTICES1
Forms name
Number of
responses per
respondents
Average
burden per
response
Total
burden
hours
Incident Report ......................................................................................................
Incident Report ......................................................................................................
Incident Report ......................................................................................................
25
25
200
1
3
5
30/60
30/60
30/60
12.5
37.5
500
Total ................................................................................................................
........................
..........................
....................
550
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–15655 Filed 7–16–24; 8:45 am]
National Institutes of Health
BILLING CODE 4150–36–P
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
19:21 Jul 16, 2024
Jkt 262001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
amended, notice is hereby given of a
meeting of the AIDS Research Advisory
Committee, NIAID.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
E:\FR\FM\17JYN1.SGM
17JYN1
58168
Federal Register / Vol. 89, No. 137 / Wednesday, July 17, 2024 / Notices
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: September 9, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Report of Division Director
and Division Staff.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Pamela Gilden,
Branch Chief, Science Planning and
Operations Branch, Division of AIDS,
National Institute of Allergy and
Infectious Diseases, National Institutes
of Health, 5601 Fishers Lane, MSC 9831,
Rockville, MD 20852–9831, 301–594–
9954, pamela.gilden@nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
ddrumheller on DSK120RN23PROD with NOTICES1
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–15710 Filed 7–16–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:21 Jul 16, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meetings will be open to the public
as indicated below, with attendance
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council.
Date: September 9, 2024.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Room 3F40B, Bethesda, MD 20892–
9834, (240) 669–5036, poeky@
mail.nih.gov.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council Microbiology and
Infectious Diseases Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 2, Rockville, MD 20892
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division
Director and Division Staff.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 2, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Room 3F40B, Bethesda, MD 20892–
9834, (240) 669–5036, poeky@
mail.nih.gov.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council Immunology and
Transplantation Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 1, Rockville, MD 20892
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division
Director and Division Staff.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Garden Room 1, Rockville, MD 20892
(Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural
Activities, National Institutes of Health,
NIAID, National Institutes of Health,
5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892–9834, (240) 669–
5036, poeky@mail.nih.gov.
Name of Committee: National
Advisory Allergy and Infectious
Diseases Council Acquired
Immunodeficiency Syndrome
Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy
and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Grand Hall, Rockville, MD 20892
(Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division
Director and Division Staff.
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 89, Number 137 (Wednesday, July 17, 2024)]
[Notices]
[Pages 58167-58168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15710]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the AIDS Research
Advisory Committee, NIAID.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other
[[Page 58168]]
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting. The meeting can be accessed from the
NIH Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: AIDS Research Advisory Committee, NIAID.
Date: September 9, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Pamela Gilden, Branch Chief, Science Planning and
Operations Branch, Division of AIDS, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, 5601 Fishers Lane,
MSC 9831, Rockville, MD 20852-9831, 301-594-9954,
[email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a meeting
on campus or at an off-campus federal facility will be asked to show
one form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-15710 Filed 7-16-24; 8:45 am]
BILLING CODE 4140-01-P
